NYSE:PBH

Prestige Consumer Healthcare - PBH Stock Forecast, Price & News

$49.83

-0.34 (-0.68%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $49.81
▼
$51.28
50-Day Range: $48.72
▼
$61.12
52-Week Range: $48.51
▼
$63.83

Volume: 363,364 shs
Average Volume: 299,078 shs
Market Capitalization: $2.48 billion

P/E Ratio: 12.49
Dividend Yield: N/A
Price Target: $80.50

Prestige Consumer Healthcare MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 61.5% Upside
$80.50 Price Target
Short Interest: Bearish
2.66% of Float Sold Short
Dividend Strength: N/A
Sustainability: -2.35
Upright™ Environmental Score
News Sentiment: 0.02
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 6.18%
From $4.21 to $4.47 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Consumer Discretionary Sector

179th out of 281 stocks

Pharmaceutical Preparations Industry

242nd out of 547 stocks

3.3

Analyst's Opinion

Consensus Rating
Prestige Consumer Healthcare has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $80.50, Prestige Consumer Healthcare has a forecasted upside of 61.5% from its current price of $49.83.
Amount of Analyst Coverage
Prestige Consumer Healthcare has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.66% of the float of Prestige Consumer Healthcare has been sold short.
Short Interest Ratio / Days to Cover
Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 4.8.
Change versus previous month
Short interest in Prestige Consumer Healthcare has recently increased by 4.80%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Prestige Consumer Healthcare does not currently pay a dividend.
Dividend Growth
Prestige Consumer Healthcare does not have a long track record of dividend growth.

3.5

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Prestige Consumer Healthcare has received a 42.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Dental floss", "Topical capsaicin", "Mouthwash", "Lice shampoo", "Montelukast", and "Yeast infection medicine" products. See details.
Environmental Sustainability
The Environmental Impact score for Prestige Consumer Healthcare is -2.35.

2.2

News and Social Media Coverage

News Sentiment
Prestige Consumer Healthcare has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Consumer Discretionary companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Prestige Consumer Healthcare this week, compared to 1 article on an average week.
Search Interest
1 people have searched for PBH on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.60% of the stock of Prestige Consumer Healthcare is held by insiders.
Percentage Held by Institutions
99.37% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Prestige Consumer Healthcare are expected to grow by 6.18% in the coming year, from $4.21 to $4.47 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Prestige Consumer Healthcare is 12.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.98.
Price to Earnings Ratio vs. Sector
The P/E ratio of Prestige Consumer Healthcare is 12.49, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 9.69.
Price to Earnings Growth Ratio
Prestige Consumer Healthcare has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Prestige Consumer Healthcare has a P/B Ratio of 1.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Prestige Consumer Healthcare (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

October 2, 2022 | americanbankingnews.com

Prestige Consumer Healthcare (NYSE:PBH) Price Target Lowered to $63.00 at Oppenheimer

September 28, 2022 | nasdaq.com

Here's Why Prestige Brands (PBH) is a Strong Value Stock

September 22, 2022 | nasdaq.com

Prestige Consumer Healthcare Inc Shares Near 52-Week Low - Market Mover

September 18, 2022 | finance.yahoo.com

Declining Stock and Decent Financials: Is The Market Wrong About Prestige Consumer Healthcare Inc. (NYSE:PBH)?

September 17, 2022 | nasdaq.com

Prestige Consumer Healthcare Inc Shares Close in on 52-Week Low - Market Mover

September 7, 2022 | finance.yahoo.com

Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference

September 5, 2022 | msn.com

Factors Working Well for Prestige Consumer

September 2, 2022 | seekingalpha.com

Holding Prestige Consumer Healthcare

September 2, 2022 | nasdaq.com

Recent 5.3% pullback isn't enough to hurt long-term Prestige Consumer Healthcare (NYSE:PBH) shareholders, they're still up 59% over 3 years

August 29, 2022 | finance.yahoo.com

Down 12.1% in 4 Weeks, Here's Why Prestige Brands (PBH) Looks Ripe for a Turnaround

August 27, 2022 | reuters.com

Prestige Consumer Healthcare Inc

August 23, 2022 | finance.yahoo.com

Prestige Brands (PBH) Moves to Buy: Rationale Behind the Upgrade

August 7, 2022 | seekingalpha.com

Prestige Consumer Healthcare Inc.'s (PBH) CEO Ron Lombardi on Q1 2023 Results - Earnings Call Transcript

August 7, 2022 | seekingalpha.com

Prestige Consumer Healthcare Inc. 2023 Q1 - Results - Earnings Call Presentation

August 4, 2022 | finance.yahoo.com

Prestige Consumer (PBH) Q1 Earnings Top Estimates, Revenues Up

August 4, 2022 | ca.finance.yahoo.com

Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023

July 26, 2022 | finance.yahoo.com

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

July 20, 2022 | nasdaq.com

Do Prestige Consumer Healthcare's (NYSE:PBH) Earnings Warrant Your Attention?

July 18, 2022 | nasdaq.com

Prestige Consumer Healthcare (PBH) Shares Cross Below 200 DMA

July 12, 2022 | uk.finance.yahoo.com

Why shares in Prestige Consumer Healthcare may be able to withstand economic turmoil

July 11, 2022 | finance.yahoo.com

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results

June 27, 2022 | uk.finance.yahoo.com

What factors will move the Prestige Consumer Healthcare share price?

June 24, 2022 | nasdaq.com

PBH Makes Bullish Cross Above Critical Moving Average

June 14, 2022 | finance.yahoo.com

Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High

June 9, 2022 | finance.yahoo.com

Prestige Consumer Healthcare (NYSE:PBH) shareholders have earned a 23% CAGR over the last three years

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Company Calendar

Last Earnings: 11/04/2021
Today: 10/02/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceutical preparations
Sub-Industry: Personal Products
Sector: Consumer Discretionary
Current Symbol: NYSE:PBH
CUSIP: 74112D10
CIK: 1295947
Web: www.prestigebrands.com
Phone: (914) 524-6800
Fax: 302-674-5266
Employees: 505
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $80.50
High Stock Price Forecast: $126.00
Low Stock Price Forecast: $63.00
Forecasted Upside/Downside: +61.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.99
Trailing P/E Ratio: 12.49
Forward P/E Ratio: 11.84
P/E Growth: 1.49
Net Income: $205.38 million
Net Margins: 18.53%
Pretax Margin: 23.48%
Return on Equity: 13.27%
Return on Assets: 5.55%

Debt

Debt-to-Equity Ratio: 0.93
Current Ratio: 2.09
Quick Ratio: 1.23

Sales & Book Value

Annual Sales: $1.09 billion
Price / Sales: 2.28
Cash Flow: $4.80 per share
Price / Cash Flow: 10.38
Book Value: $31.43 per share
Price / Book: 1.59

Miscellaneous

Outstanding Shares: 49,760,000
Free Float: 48,967,000
Market Cap: $2.48 billion
Optionable: Optionable
Beta: 0.55

Key Executives

Mr. Ronald M. Lombardi (Age 58)
Chairman, Pres & CEO
Comp: $2.73M

Ms. Christine Sacco (Age 46)
Chief Financial Officer
Comp: $1.26M

Mr. Jeffrey Zerillo (Age 61)
Sr. VP of Operations
Comp: $580.88k

Mr. William C. P'Pool (Age 57)
Sr. VP, Gen. Counsel & Corp. Sec.
Comp: $955.34k

Mr. Adel Mekhail (Age 61)
Exec. VP of Marketing & Sales
Comp: $971.47k

Mr. Philip David Terpolilli
Director of Investor Relations

Dean Siegal
Director of Communications

Ms. Mary Beth Fritz
Sr. VP of Quality & Regulatory Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PBH Stock - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PBH shares.
View PBH analyst ratings or view top-rated stocks.
What is Prestige Consumer Healthcare's stock price forecast for 2022?: 4 Wall Street analysts have issued 12-month target prices for Prestige Consumer Healthcare's shares. Their PBH share price forecasts range from $63.00 to $126.00. On average, they expect the company's share price to reach $80.50 in the next year. This suggests a possible upside of 61.5% from the stock's current price.
View analysts price targets for PBH or view top-rated stocks among Wall Street analysts.
How have PBH shares performed in 2022?: Prestige Consumer Healthcare's stock was trading at $60.65 at the start of the year. Since then, PBH shares have decreased by 17.8% and is now trading at $49.83.
View the best growth stocks for 2022 here.
When is Prestige Consumer Healthcare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our PBH earnings forecast.
How were Prestige Consumer Healthcare's earnings last quarter?: Prestige Consumer Healthcare Inc. (NYSE:PBH) issued its earnings results on Thursday, November, 4th. The company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.99 by $0.03. The business earned $276.23 million during the quarter, compared to analysts' expectations of $261.23 million. Prestige Consumer Healthcare had a net margin of 18.53% and a trailing twelve-month return on equity of 13.27%. The firm's revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.78 earnings per share.
What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?: Prestige Consumer Healthcare updated its FY 2023 earnings guidance on Thursday, August, 18th. The company provided earnings per share guidance of $4.18-$4.23 for the period. The company issued revenue guidance of $1.12 billion-$1.13 billion, compared to the consensus revenue estimate of $1.12 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?: 8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Prestige Consumer Healthcare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).
What is Prestige Consumer Healthcare's stock symbol?: Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."
How do I buy shares of Prestige Consumer Healthcare?: Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Prestige Consumer Healthcare's stock price today?: One share of PBH stock can currently be purchased for approximately $49.83.
How much money does Prestige Consumer Healthcare make?: Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $2.48 billion and generates $1.09 billion in revenue each year. The company earns $205.38 million in net income (profit) each year or $3.99 on an earnings per share basis.
How many employees does Prestige Consumer Healthcare have?: The company employs 505 workers across the globe.
How can I contact Prestige Consumer Healthcare?: Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.

This page (NYSE:PBH) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Prestige Consumer Healthcare - PBH Stock Forecast, Price & News

Prestige Consumer Healthcare MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability